AGTR1 and preeclampsia: Numerous studies have shown that women with preeclampsia possess autoantibodies against angiotensin II type 1 receptors (AT1-AAB), which bind to and activate the AT1 receptor, thus provoking biological responses relevant to the pathogenesis of preeclampsia [4-8].